COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic
| Autor: | Vijay Duggirala, Eric R. Schumacher, Michael B. Streiff, Kevin J. O'Leary, Justin J Choi, Geraldine E. Ménard, Margaret C. Fang, David F. Hemsey, Michael Y. Lin, Daniel J. Brotman, Jeffrey L. Schnipper, David G. Sterken, S Ryan Greysen, James E. Anstey, Shoshana J. Herzig, Todd E.H. Hecht, Anna L. Parks, Kwame Dapaah-Afriyie, Anne S. Linker, Daniel P. Hunt, Neera Ahuja, Valerie M. Vaughn, Andrew Dunn, Andrew D. Auerbach, William Collins, Melissa L. P. Mattison, Matthew A. Pappas, Sanjay Bhandari |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Pulmonary embolism (PE)
medicine.medical_specialty Consensus Deep vein thrombosis (DVT) Coronavirus disease 2019 (COVID-19) Letter to the Editors-in-Chief Risk Assessment Anticoagulation Clinical Protocols Risk Factors Coagulopathy Pandemic medicine Humans Thrombophilia Venous thromboembolism (VTE) cardiovascular diseases Dosing Healthcare Disparities Practice Patterns Physicians' Intensive care medicine Blood Coagulation Venous Thrombosis Academic Medical Centers business.industry Anticoagulants COVID-19 Thrombosis Venous Thromboembolism Hematology Heparin medicine.disease United States COVID-19 Drug Treatment Coronavirus Treatment Outcome Pulmonary Embolism business Venous thromboembolism medicine.drug |
| Zdroj: | Thrombosis Research |
| ISSN: | 0049-3848 |
| DOI: | 10.1016/j.thromres.2020.09.018 |
| Popis: | As the Coronavirus disease 2019 (COVID-19) pandemic spread to the US, so too did descriptions of an associated coagulopathy and thrombotic complications. Hospitals created institutional protocols for inpatient management of COVID-19 coagulopathy and thrombosis in response to this developing data. We collected and analyzed protocols from 21 US academic medical centers developed between January and May 2020. We found greatest consensus on recommendations for heparin-based pharmacologic venous thromboembolism (VTE) prophylaxis in COVID-19 patients without contraindications. Protocols differed regarding incorporation of D-dimer tests, dosing of VTE prophylaxis, indications for post-discharge pharmacologic VTE prophylaxis, how to evaluate for VTE, and the use of empiric therapeutic anticoagulation. These findings support ongoing efforts to establish international, evidence-based guidelines. Highlights • COVID-19 protocols agreed on heparin-based venous thromboembolism prophylaxis. • Disagreement on thrombosis risk and diagnosis, D-dimer, empiric anticoagulation • Cumulative incidence of COVID-19 did not correlate with specific recommendations. • Framework for frontline providers and hospitals to evaluate practices and outcomes |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect